Models, Economic

• 

  Subject Areas on Research

  • A Blue Ocean Strategy for Palliative Care: Focus on Family Caregivers. 
  • A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability. 
  • A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus. 
  • A clinical economics workstation for risk-adjusted health care cost management. 
  • A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. 
  • A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa. 
  • A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer. 
  • A framework to evaluate the economic impact of pharmacogenomics. 
  • A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. 
  • A new ambulatory classification and funding model for radiation oncology: non-admitted patients in Victorian hospitals. 
  • A predictive model for neutropenia associated with cancer chemotherapy. 
  • A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II. 
  • A value model for evaluating homeland security decisions. 
  • Advancing Value-Based Models for Heart Failure: A Call to Action From the Value in Healthcare Initiative's Value-Based Models Learning Collaborative. 
  • An organizational and economic framework for restructuring psychiatric nurse labor use. 
  • Analysis of alternative pathways for reducing nitrogen oxide emissions. 
  • Arrow's concept of the health care consumer: a forty-year retrospective. 
  • Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project. 
  • Balancing the benefits and costs of colony-stimulating factors: a current perspective. 
  • Bariatric surgery as a means to decrease mortality in women with type I endometrial cancer - An intriguing option in a population at risk for dying of complications of metabolic syndrome. 
  • Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective? 
  • Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis. 
  • Choosing a Time Horizon in Cost and Cost-effectiveness Analyses. 
  • Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations. 
  • Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study. 
  • Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. 
  • Conducting an economic analysis to assess the electrocardiogram's value. 
  • Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare. 
  • Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer. 
  • Cost analysis of abdominal, laparoscopic, and robotic-assisted myomectomies. 
  • Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. 
  • Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancer. 
  • Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer. 
  • Cost effectiveness in Canada of eptifibatide treatment for acute coronary syndrome patients using PURSUIT subgroup analysis. 
  • Cost effectiveness of a gene expression score and myocardial perfusion imaging for diagnosis of coronary artery disease. 
  • Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network. 
  • Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients. 
  • Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma. 
  • Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? 
  • Cost-effectiveness analysis of free vascularized fibular grafting for osteonecrosis of the femoral head. 
  • Cost-effectiveness analysis of the first-line therapies for nicotine dependence. 
  • Cost-effectiveness as an outcome in randomized clinical trials. 
  • Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers? 
  • Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals. 
  • Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis. 
  • Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation. 
  • Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. 
  • Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention. 
  • Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease. 
  • Cost-effectiveness of prophylactic appendectomy: a Markov model. 
  • Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. 
  • Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. 
  • Demonstration of a sustainable community-based model of care across the palliative care continuum. 
  • Does Medicaid pay more to a program of all-inclusive care for the elderly (PACE) than for fee-for-service long-term care? 
  • Dynamics of rural-urban migration in India: 1960-1981. 
  • Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164. 
  • Economic analysis in eye disease. 
  • Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms. 
  • Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer. 
  • Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy. 
  • Economic analysis of the military health professions scholarship program for neurosurgeons. 
  • Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty. 
  • Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C. 
  • Economic impact of drug-eluting stents on hospital systems: a disease-state model. 
  • Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs. 
  • Editorial comment--what can models teach us about stroke treatment? Sorting out the missing bits. 
  • Effects of indirect and additional direct costs on the risk threshold for prophylaxis with colony-stimulating factors in patients at risk for severe neutropenia from cancer chemotherapy. 
  • Estimates of state-level health-care expenditures associated with disability. 
  • Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model. 
  • Estimating the Annual Incremental Cost of Several Complications Following Pulmonary Lobectomy. 
  • Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach. 
  • Estimating the impacts of conservation on ecosystem services and poverty by integrating modeling and evaluation. 
  • Estimation and validation of a multiattribute model of Alzheimer disease progression. 
  • Factors associated with persistently high-cost health care utilization for musculoskeletal pain. 
  • Factors that influence the presence of a hospice in a rural community. 
  • Financial Forecasting and Stochastic Modeling: Predicting the Impact of Business Decisions. 
  • Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives. 
  • Financial implications of coverage for laparoscopic adjustable gastric banding. 
  • Foundations of neuroeconomics: from philosophy to practice. 
  • Fully Capitated Payment Breakeven Rate for a Mid-Size Pediatric Practice. 
  • Funds flow in academic neurology: A potential path to financial success. 
  • Getting used to it: the adaptive global utility model. 
  • Hip Fractures in Older Adults in 2019. 
  • How does cost matter in health-care discrete-choice experiments? 
  • Identity economics and the brain: uncovering the mechanisms of social conflict. 
  • Implications of a sugar-sweetened beverage (SSB) tax when substitutions to non-beverage items are considered. 
  • Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention. 
  • Incremental Cost-Effectiveness Analysis of Gestational Diabetes Mellitus Screening Strategies in Singapore. 
  • Incremental cost-effectiveness of evidence-based non-surgical weight loss strategies. 
  • Insecticide Resistance and Malaria Vector Control: The Importance of Fitness Cost Mechanisms in Determining Economically Optimal Control Trajectories 
  • Integration of EEG lead placement templates into traditional technologist-based staffing models reduces costs in continuous video-EEG monitoring service. 
  • Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions. 
  • Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). 
  • Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis. 
  • Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions). 
  • Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). 
  • Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis. 
  • Measuring the burden of multimorbidity among Medicare beneficiaries via condition counts and cumulative duration. 
  • Measuring the effect of policy interventions at the population level: some methodological concerns. 
  • Medical cost trajectories and onsets of cancer and noncancer diseases in US elderly population. 
  • Micro-level explanations for emergent patterns of self-governance arrangements in small-scale fisheries-A modeling approach. 
  • Modeling Semicontinuous Longitudinal Expenditures: A Practical Guide. 
  • Modeling for health care and other policy decisions: uses, roles, and validity. 
  • Modeling the Budgetary Impact of Payer Utilization Management Strategies: An Adapted Framework Based on Lessons Learned. 
  • Modeling the Potential Economic Impact of the Medicare Comprehensive Care for Joint Replacement Episode-Based Payment Model. 
  • Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults. 
  • Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials. 
  • Novel Approaches to Value Assessment Beyond the Cost-Effectiveness Framework. 
  • Obstructed labor and caesarean delivery: the cost and benefit of surgical intervention. 
  • Oncology Care Model: Short- and Long-Term Considerations in the Context of Broader Payment Reform. 
  • Outlook for Alternative Payment Models in Fee-for-Service Medicare. 
  • Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. 
  • Physical and economic potential of geological CO 2 storage in saline aquifers 
  • Political economy of marine reserves: understanding the role of opportunity costs. 
  • Predicting Costs Exceeding Bundled Payment Targets for Total Joint Arthroplasty. 
  • Predictors of costs of caring for elderly patients discharged with heart failure. 
  • Pricing strategy to promote fruit and vegetable purchase in high school cafeterias. 
  • Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. 
  • Qualitative evaluation of South Carolina's Postpartum/Infant Home Visit program. 
  • Re: Uses and misuses of multicriteria decision analysis (MCDA) in environmental decision making. 
  • Reducing the costs of phase III cardiovascular clinical trials. 
  • Registry-based trials: a potential model for cost savings? 
  • Response to: reducing the cost of continuous EEG monitoring. 
  • Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. 
  • Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP). 
  • Solo versus group practice in the medical profession: the influence of malpractice risk. 
  • Statistical considerations in economic evaluations: a guide for cardiologists. 
  • Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective. 
  • Surgeons' economic profiles: can we get the "right" answers? 
  • Surgery for hip fracture yields societal benefits that exceed the direct medical costs. 
  • Surveillance issues in inflammatory bowel disease: ulcerative colitis. 
  • The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial. 
  • The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS study. 
  • The economic burden of anxiety disorders in the 1990s. 
  • The oncology care model and the future of alternative payment models: A gynecologic oncology perspective. 
  • Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective. 
  • Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure. 
  • Toward a broader view of values in cost-effectiveness analysis of health. 
  • Translating upwards: linking the neural and social sciences via neuroeconomics. 
  • Treating multidrug-resistant tuberculosis in community settings: a wise investment. 
  • US valuation of health outcomes measured using the PROMIS-29. 
  • Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools. 
  • Using and improving the social cost of carbon 
  • Using private demand studies to calculate socially optimal vaccine subsidies in developing countries. 
  • Validating a Budget Impact Model Using Payer Insight and Claims Data: A Framework and Case Study. 
  • Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening. 
  • Valuing morbidity: an integration of the willingness-to-pay and health-status index literatures. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Huettel, Scott, Professor in the Department of Psychology and Neuroscience, Duke Science & Society
  • Kranton, Rachel, James B. Duke Distinguished Professor of Economics, Economics
  • Myers, Evan Robert, Walter L. Thomas Distinguished Professor of Obstetrics and Gynecology in the School of Medicine, Duke Cancer Institute
  • Newell, Richard G., Adjunct Professor, Environmental Sciences and Policy
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society